EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $232,000 | -8.7% | 4,986 | -6.0% | 0.01% | 0.0% |
| Q2 2020 | $254,000 | -78.2% | 5,304 | -79.0% | 0.01% | -75.0% |
| Q1 2020 | $1,164,000 | -47.0% | 25,300 | -30.9% | 0.03% | -20.0% |
| Q4 2019 | $2,198,000 | -9.1% | 36,590 | -14.4% | 0.04% | -7.0% |
| Q3 2019 | $2,419,000 | +27.1% | 42,768 | +25.1% | 0.04% | +43.3% |
| Q2 2019 | $1,903,000 | +74.3% | 34,182 | +58.0% | 0.03% | +87.5% |
| Q1 2019 | $1,092,000 | +405.6% | 21,632 | +303.1% | 0.02% | +433.3% |
| Q4 2018 | $216,000 | -69.4% | 5,366 | -47.4% | 0.00% | -70.0% |
| Q3 2018 | $707,000 | -35.0% | 10,203 | -29.0% | 0.01% | -37.5% |
| Q2 2018 | $1,087,000 | +21.0% | 14,369 | -15.7% | 0.02% | +23.1% |
| Q1 2018 | $898,000 | -67.8% | 17,044 | -67.4% | 0.01% | -68.3% |
| Q4 2017 | $2,791,000 | -73.6% | 52,241 | -70.5% | 0.04% | -73.5% |
| Q3 2017 | $10,564,000 | -23.6% | 177,136 | +1.1% | 0.16% | -20.1% |
| Q2 2017 | $13,823,000 | +14.9% | 175,214 | +20.8% | 0.19% | +26.8% |
| Q1 2017 | $12,027,000 | +73.4% | 145,012 | +65.9% | 0.15% | +71.9% |
| Q4 2016 | $6,937,000 | +151.1% | 87,429 | +121.5% | 0.09% | +147.2% |
| Q3 2016 | $2,763,000 | +80.4% | 39,478 | +108.4% | 0.04% | +176.9% |
| Q2 2015 | $1,532,000 | – | 18,945 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |